sotorasib

Amgen lands first FDA approval for drug targeting elusive mutation in lung cancer
MedCity News
Sat, 05/29/21 - 04:52 pm
Amgen
FDA
sotorasib
Lumakras
KRAS mutation
Amgen’s low-dose Kras curveball
EP Vantage
Thu, 04/29/21 - 10:40 am
Amgen
FDA
Lumakras
sotorasib
Amgen study data bolster prospects of KRAS-blocking cancer drug
BioPharma Dive
Thu, 01/28/21 - 11:25 pm
Amgen
sotorasib
clinical trials
KRAS mutation
cancer
Amgen plans 2020 filing for FDA approval of KRAS drug sotorasib
Fierce Biotech
Tue, 12/8/20 - 10:43 am
Amgen
FDA
sotorasib
KRAS
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Tue, 10/6/20 - 10:26 am
Amgen
clinical trials
non-small cell lung cancer
KRAS
sotorasib
Amgen publishes, presents data on therapy with ‘undruggable’ target
MedCity News
Mon, 09/21/20 - 10:33 am
Amgen
sotorasib
ESMO
AMG 510
non-small cell lung cancer